Back to search
FDAFDA · Food and drugs·Recall number D-0865-2018

Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-4810-05

Published June 13, 2018 · Recall initiated: May 29, 2018

Summary

FDA records drug Class III recall D-0865-2018, published June 13, 2018 and initiated May 29, 2018. Recalling firm: Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 275400 cups; Lot: Lot: B5B8 Exp. 07/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Resuspension problems: Out of specification for appearance and resuspendability.

What to do

Voluntary: Firm initiated · Letter

Get an email if NYSTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NYSTATIN
Manufacturer
Pharmaceutical Associates Inc
Distributor
Nationwide
UPC
0301210810022
Lot
Lot: B5B8 Exp. 07/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-4810-05 recalled?

Yes. FDA published recall D-0865-2018 on June 13, 2018. Reported hazard: Resuspension problems: Out of specification for appearance and resuspendability.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NYSTATIN. UPC: 0301210810022.